- $845.29m
- $754.53m
- $216.93m
- 98
- 27
- 29
- 50
Annual income statement for Docebo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 62.9 | 104 | 143 | 181 | 217 |
| Cost of Revenue | |||||
| Gross Profit | 51.4 | 83.5 | 115 | 146 | 176 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 70.5 | 118 | 139 | 185 | 196 |
| Operating Profit | -7.63 | -13.4 | 4.18 | -3.71 | 21.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.68 | -13.4 | 7.78 | 4.85 | 23.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.02 | -13.6 | 7.02 | 2.84 | 26.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.02 | -13.6 | 7.02 | 2.84 | 26.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.02 | -13.6 | 7.02 | 2.84 | 26.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.277 | -0.414 | 0.234 | 0.196 | 0.947 |